66 μg (n = 10) (260/280:1.55 ± 0.31) at RNAlater® storage, respectively. Only small total RNA could be obtained by samples of RNAlater® storage. The quality

and degradation of total RNA was checked by electrophoresis. In EUS-FNA specimens, RNA degradations were observed in all the samples of frozen storage. On the other hand, in RNAlater® stored samples, 5 of 13 samples showed both bands of 16 s and 28 s rRNA. In pancreatic juice samples, almost all sample of frozen storage showed two bands of rRNA, but in RNAlater® stored samples, almost all samples showed RNA degradations. After the treatment with DNase, the 0.1-2 μg of total RNA was amplified using Eberwine’s method. The average of aRNA amplifications in EUS-FNA specimens were 129 ± 99 and 252 ± 253 fold in frozen and RNAlater® storage, respectively. In pancreatic juices samples, 298 ± 142 and 235 ± 149 in frozen and RNAlater® storage, ABT-888 supplier respectively. The RNA sample with good quality confirmed by electrophoresis showed efficient aRNA amplification (Table S1, Additional file 1 and Table S2, Additional file 2). Gene Expression Analysis We optimized the technique of enzymatic hybridization signal amplification by applying TSA technology to the 3D structure of our microarray [12]. As a result, fluorescent molecules accumulated at the surface of the multiple selleck chemicals llc pores, and approximately 1000-fold signal amplification

was realized when compared with the conventional microarray method. Each hybridization was performed with only 50 ng of aRNA labeled with biotin. The samples with two-bands of rRNAs in electrophoresis and with an efficient rate of aRNA amplification (over 300-fold) were analyzable on the microarray hybridization showing sufficient signal intensity on most of the spots. However, the other samples did not hybridize on the microarray at all. The analyzable rate with the microarray was 46% (6/13)

in EUS-FNA specimens of RNAlater® storage. In pancreatic juices, analyzable rate was 67% (4/6) in frozen storage Endonuclease samples and 20% (2/10) in RNAlater® storage. After each hybridization, hybridization images were automatically taken by the CCD camera integrated in the FD10, and original image analysis software calculated the fluorescence intensity of each spot and subtracted the background value. Six of those data from EUS-FNA specimens and six data from the pancreatic juice previously obtained were LY2109761 clinical trial applied to hierarchical clustering analysis using Spotfire DecisionSite Functional Genomics http://​www.​spotfire.​com/​ with 25 genes, which showed sufficient signal intensity in most of the samples. In the gene expression analysis, the samples were classified into two clusters, EUS-FNA samples and pancreatic juice samples (pellets after centrifugation), by the 1st clustering (Figure 3, line A). The cluster of the EUS-FNA sample was further classified into cancerous or non-cancerous clusters by the 2nd clustering (Figure 3, line B).